Alexander Bystritsky
Psychiatry · Los Angeles, CANPI 1053428011
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,643 of the $9,246 with a category attached, or 82.7%. Otsuka Pharmaceutical Development & Commercialization, Inc. accounts for 82.7% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $6,860, more than ten times the $251 reported in 2019. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $298.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$8K
- Boehringer Ingelheim$1K
- Sunovion Pharmaceuticals Inc.$139
- Takeda Pharmaceuticals U.S.A., Inc.$119
- Vanda Pharmaceuticals Inc.$71
- Novo Nordisk$63
- plus $169 from 6 others
Across 76 payments — averaging $10,901 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$303K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$156K
- Boehringer Ingelheim$130K
- Biohaven Pharmaceuticals, Inc.$73K
- Brainsway USA Inc$40K
- Takeda Pharmaceuticals U.S.A., Inc.$31K
- plus $95K from 6 others
What the payments were for
- Consulting fees$7,64383%
- Travel & lodging$7168%
- Food & beverage$88610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$9,246 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 25 | $237 |
| Gabapentin | 19 | $167 |
| Eszopiclone | 11 | $156 |
| Zolpidem Tartrate | 12 | $130 |
| Sertraline Hcl | 22 | $30 |
| Diazepam | 13 | $8 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Los Angeles
- Jakub JurosLos Angeles$394K
- Derek OttLos Angeles$329K
- William WirshingLos Angeles$205K
- Gil HoftmanLos Angeles$200K
- Lon SchneiderLos Angeles$156K
- Stephen MarderLos Angeles$103K
- John BrooksLos Angeles$80K
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.